Pages that link to "Q35176037"
Jump to navigation
Jump to search
The following pages link to Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma (Q35176037):
Displaying 13 items.
- Understanding the role of the kynurenine pathway in human breast cancer immunobiology (Q26773472) (← links)
- Immune modulation of CD4( )CD25( ) regulatory T cells by zoledronic acid (Q36204083) (← links)
- Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells (Q36544608) (← links)
- Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion (Q37190280) (← links)
- Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors (Q37190433) (← links)
- Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor (Q37252683) (← links)
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications (Q37308207) (← links)
- Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. (Q52688134) (← links)
- Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells (Q59792450) (← links)
- Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells (Q64099099) (← links)
- ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer. (Q65000057) (← links)
- ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma (Q90191771) (← links)
- The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy (Q92190778) (← links)